1. Medeiros LJ et al: Cutaneous lymphoid hyperplasia: Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. J Am Acad Dermatol 21:929-942, 1989
2. Caro WA, Helwig HB: Cutaneous lymphoid hyperplasia. Cancer 24(3):487-502, 1969
3. Albrecht J, Fine LA, Piette W: Drug-associated lymphoma and pseudolymphoma: Recognition and management. Dermatol Clin 25(2):233-244, vii, 2007
4. Ploysangam T, Breneman DL, Mutasim DF: Cutaneous pseudolymphomas. J Am Acad Dermatol 38(6 Pt 1):877-895; quiz 896-877, 1998
5. Wood G: The Benign and Malignant Cutaneous Lymphoproliferative Disorders Including Mycosis Fungoides. Baltimore, MD, Williams and Wilkins, 2001
6. Gilliam
AC, Wood GS: Cutaneous lymphoid hyperplasias.
Semin Cutan Med Surg 19(2):133-141, 2000
7. Maubec E et al: Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol 52(4):623-629, 2005
8. McComb ME, Telang GH, Vonderheid
EC: Secondary syphilis presenting as pseudolymphoma of the skin.
J Am Acad Dermatol 49(Suppl. 2 Case Reports):S174-S176, 2003
9. Mitani N et al: A case of cutaneous T cell pseudolymphoma in a patient with Helicobacter pylori infection. Dermatology 213(2):156-158, 2006
10. Magro CM et al: Drug-induced reversible lymphoid dyscrasia: A clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol 34(2):119-129, 2003
11. Magro CM, Crowson AN, Schapiro BL: The interstitial granulomatous drug reaction: A distinctive clinical and pathological entity. J Cutan Pathol 25(2):72-78, 1998
12. Magro CM, Crowson AN: Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. J Am Acad Dermatol 32(3):419-428, 1995
13. Lee MW et al: Clinicopathologic study of cutaneous pseudolymphomas. J Dermatol 32(7):594-601, 2005
14. Rijlaarsdam JU, Willemze R: Cutaneous pseudolymphomas: Classification and differential diagnosis. Semin Dermatol 13(3):187-196, 1994
15. Ramsay B et al: Acral pseudolymphomatous angiokeratoma of children. Arch Dermatol 126(11):1524-1525, 1990
16. Kiyohara T et al: Linear acral pseudolymphomatous angiokeratoma of children (APACHE): Further evidence that APACHE is a cutaneous pseudolymphoma. J Am Acad Dermatol 48(Suppl. 2):S15-S17, 2003
17. Rodriguez Pinilla SM et al: Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 33(1):81-90, 2009
18. Rijlaarsdam JU et al: Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients. Cancer 69(3):717-724, 1992
19. Bendelac A et al: Cutaneous pheomorphic T cell lymphoma. Immunologic, virologic, and T-cell receptor gene rearrangement studies in one European case with initial pseudolymphoma presentation. J Am Acad Dermatol 15(4 Pt 1):657-664, 1986
20. Griesser H, Feller
AC, Sterry W: T-cell receptor and immunoglobulin gene rearrangements in cutaneous T-cell-rich pseudolymphomas.
J Invest Dermatol 95(3):292-295, 1990
21. Arai E, Shimizu M, Hirose T: A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis. Hum Pathol 36(5):505-511, 2005
22. Gerlini G et al: Specific immune therapy-related cutaneous B-cell pseudolymphoma with following dissemination. J Eur Acad Dermatol Venereol 17(2):208-212, 2003
23. Salama S: Primary cutaneous B-cell lymphoma and lymphoproliferative disorders of skin: current status of pathology and classification. Am J Clin Pathol 114(Suppl.):S104-S128, 2000
24. Cerroni L, Kerl H: Diagnostic immunohistology: Cutaneous lymphomas and pseudolymphomas. Semin Cutan Med Surg 18(1):64-70, 1999
25. Cerroni L et al: bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 102(2):231-235, 1994
26. Leinweber B et al: Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am J Dermatopathol 26(1):4-13, 2004
27. Willemze R et al: WHO-EORTC classification for cutaneous lymphomas. Blood 105(10):3768-3785, 2005
28. Nihal M et al: Cutaneous lymphoid hyperplasia: A lymphoproliferative continuum with lymphomatous potential. Hum Pathol 34(6):617-622, 2003
29. Bouloc A et al: Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. Arch Dermatol 135(2):168-172, 1999
30. Hammer E et al: Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol 28(3):426-433, 1993
31. Wood GS et al: Clonal rearrangements of immunoglobulin genes and progression to B-cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol 135:13-19, 1989
32. Rijlaarsdam U et al: Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: Differential diagnostic and pathogenetic aspects. J Invest Dermatol 99(6):749-754, 1992
33. Holm N et al: The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol 29(8):447-452, 2002
34. Bachelez H et al: Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma. J Clin Invest 101(11):2506-2516, 1998
35. Beltraminelli H et al: Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: A cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol 31(4):317-322, 2009
36. Garcia CF et al: Cutaneous follicular lymphoma. Am J Surg Pathol 10:454-463, 1986
37. Harris NL et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84(5):1361-1392, 1994
38. Arai E et al: Lymphomatoid keratosis: An epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases. Arch Dermatol 143(1):53-59, 2007
39. Kazakov DV et al: Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: A study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas. Am J Surg Pathol 32(10):1468-1478, 2008
40. Cheuk W et al: IgG4-related Sclerosing disease: A potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol 33(11):1713-1719, 2009
41. Yamamoto M et al: The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome–Expansion of SIPS to the territory of Castleman's disease. Rheumatology (Oxford) 48(7):860-862, 2009
42. El-Dars LD et al: Lymphocytoma cutis treated with topical
tacrolimus.
Clin Exp Dermatol 30(3):305-307, 2005
43. Takeda H et al: Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology 211(3):264-266, 2005
44. Mikasa K et al: Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J Am Acad Dermatol 53(5):911-912, 2005
45. Schartz NE et al: Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy. J Am Acad Dermatol 49(1):139-141, 2003
46. Mori M et al: BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders. Eur J Cancer 39(11):1625-1631, 2003
47. Moreno-Ramirez D et al: Cutaneous pseudolymphoma in association with molluscum contagiosum in an elderly patient. J Cutan Pathol 30(7):473-475, 2003
48. Kazakov DV et al: Cutaneous lymphomas and pseudolymphomas: Newly described entities. Recent Results Cancer Res 160:283-293, 2002
49. Boudova L et al: Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: A retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol 27(5):375-386, 2005
50. Chen H et al: Kimura disease: A clinicopathologic study of 21 cases. Am J Surg Pathol 28(4):505-513, 2004
51. Satpathy A et al: Spontaneous regression of a rare tumour in a child: Angiolymphoid hyperplasia with eosinophilia of the hand: Case report and review of the literature. Br J Plast Surg 58(6):865-868, 2005
52. Miteva M et al: D2-40 highlights lymphatic vessel proliferation of angiolymphoid hyperplasia with eosinophilia. J Cutan Pathol 36(12):1316-1322, 2009
53. Sun QF et al: Kimura disease: Review of the literature. Intern Med J 38(8):668-672, 2008
54. Googe PB, Harris NL, Mihm MC Jr: Kimura's disease and angiolymphoid hyperplasia with eosinophilia: Two distinct histopathological entities. J Cutan Pathol 14(5):263-271, 1987
55. Urabe A, Tsuneyoshi M, Enjoji M: Epithelioid hemangioma versus Kimura's disease. A comparative clinicopathologic study. Am J Surg Pathol 11(10):758-766, 1987
56. Chun SI, Ji HG: Kimura's disease and angiolymphoid hyperplasia with eosinophilia: Clinical and histopathologic differences. J Am Acad Dermatol 27(6 Pt 1):954-958, 1992
57. Suzuki Y et al: The high-affinity immunoglobulin E receptor (FcepsilonRI) regulates mitochondrial calcium uptake and a dihydropyridine receptor-mediated calcium influx in mast cells: Role of the FcepsilonRIbeta chain immunoreceptor tyrosine-based activation motif. Biochem Pharmacol 75(7):1492-1503, 2008
58. Teraki Y, Katsuta M, Shiohara T: Lichen amyloidosus associated with Kimura's disease: Successful treatment with
cyclosporine.
Dermatology 204(2):133-135, 2002
59. Hobeika CM et al: Kimura's disease: Case report and review of the literature. J Thorac Imaging 20(4):298-300, 2005
60. Mariatos G et al: Epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia) in the oral mucosa. A case report and review of the literature. Oral Oncol 35(4):435-438, 1999
61. Skelton Hea: Castleman's disease in the skin; a rare lymphoid hyperplasia not previously reported in the skin. J Cutan Pathol 24:125, 1997
62. Kubota Y et al: Skin involvement in giant lymph node hyperplasia (Castleman's disease). J Am Acad Dermatol 29(5 Pt 1):778-780, 1993
63. Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29(3):670-683, 1972
64. Grossin M et al: [Subcutaneous localizations of Castleman's pseudolymphoma. Review of the literature apropos of a case]. Ann Dermatol Venereol 112(6-7):497-506, 1985
65. Cronin DM, Warnke RA: Castleman disease: An update on classification and the spectrum of associated lesions. Adv Anat Pathol 16(4):236-246, 2009
66. Chen CH et al: Possible roles of Epstein-Barr virus in Castleman disease. J Cardiothorac Surg 4:31, 2009
67. Ishiyama T et al: Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. Br J Haematol 86(3):483-489, 1994
68. Gherardi RK et al: Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood 83(9):2587-2593, 1994
69. Martinelli PT, Tyring SK: Human herpesvirus 8. Dermatol Clin 20(2):307-314, vii-viii, 2002
70. Cesarman E et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332(18):1186-1191, 1995
71. Soubrier MJ, Dubost JJ, Sauvezie BJ: POEMS syndrome: A study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 97(6):543-553, 1994
72. Wang J et al: Paraneoplastic pemphigus associated with Castleman tumor: A commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol 141(10):1285-1293, 2005
73. Sherman D et al: Reversible plane xanthoma, vasculitis, and peliosis hepatis in giant lymph node hyperplasia (Castleman's disease): A case report and review of the cutaneous manifestations of giant lymph node hyperplasia. J Am Acad Dermatol 26(1):105-109, 1992
74. Kondo M et al: [A case of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia associated with chronic renal failure]. [Article in Japanese.] Nippon Jinzo Gakkai Shi 32(10):1133-1137, 1990
75. Hisatake J et al: [Autoimmune hemolytic anemia associated with multicentric Castleman's disease with a 28-year history]. [Article in Japanese.] Rinsho Ketsueki 35(8):768-773, 1994
76. Clark SH, Duvic M, Prieto VG: Mycosis fungoides-like reaction in a patient treated with Gleevec. J Cutan Pathol 30(4):279-281, 2003
77. Cordel N et al: Usefulness of cutaneous T-cell clonality analysis for the diagnosis of cutaneous T-cell lymphoma in patients with erythroderma. Arch Pathol Lab Med 129(3):372-376, 2005
78. Orbaneja JG et al: Lymphomatoid contact dermatitis: A syndrome produced by epicutaneous hypersensitivity with clinical features and a histopathologic picture similar to that of mycosis fungoides. Contact Dermatitis 2(3):139-143, 1976
79. Alvarez-Garrido H et al: Lymphomatoid photocontact dermatitis to
benzydamine hydrochloride.
Contact Dermatitis 62(2):117-119, 2010
80. Ezzedine K, Rafii N, Heenen M: Lymphomatoid contact dermatitis to an exotic wood: A very harmful toilet seat. Contact Dermatitis 57(2):128-130, 2007
81. Houck HE, Wirth FA, Kauffman CL: Lymphomatoid contact dermatitis caused by nickel. Am J Contact Dermat 8(3):175-176, 1997
82. Fleming C et al: Lymphomatoid contact reaction to gold earrings. Contact Dermatitis 37(6):298-299, 1997
83. Park YM et al: Lymphomatoid eosinophilic reaction to gold earrings. Contact Dermatitis 40(4):216-217, 1999
84. Calzavara-Pinton P et al: Lymphomatoid allergic contact dermatitis from para-phenylenediamine. Contact Dermatitis 47:173, 2000
85. Evans AV et al: Lymphomatoid contact dermatitis to para-tertyl-butyl
phenol resin.
Clin Exp Dermatol 28(3):272-273, 2003
86. Martinez-Moran C et al: Lymphomatoid contact dermatitis. Contact Dermatitis 60(1):53-55, 2009
87. Ayala F et al: Lymphomatoid contact dermatitis. Contact Dermatitis 17(5):311-313, 1987
88. Wall LM: Lymphomatoid contact dermatitis due to ethylenediamine dihydrochloride. Contact Dermatitis 8(1):51-54, 1982
89. Schena D et al: Lymphomatoid-like contact dermatitis from cobalt naphthenate. Contact Dermatitis 33(3):197-198, 1995
90. Marliere V et al: Lymphomatoid contact dermatitis caused by isopropyl-diphenylenediamine: Two cases. J Allergy Clin Immunol 102(1):152-153, 1998
91. Braun RP et al: Cutaneous pseudolymphoma, lymphomatoid contact dermatitis type, as an unusual cause of symmetrical upper eyelid nodules. Br J Dermatol 143(2):411-414, 2000
92. Dippel E et al: Familial lymphocytic infiltration of the skin: Histochemical and molecular analysis in three brothers. Dermatology 204(1):12-16, 2002
93. Lipsker D et al: Could Jessner's lymphocytic infiltrate of the skin be a dermal variant of lupus erythematosus? An analysis of 210 cases. Dermatology 213(1):15-22, 2006
94. Ziemer M et al: Lymphocytic infiltration of the skin (Jessner-Kanof) but not reticular erythematous mucinosis occasionally represents clinical manifestations of Borrelia-associated pseudolymphoma. Br J Dermatol 161(3):583-590, 2009
95. Caroli UM et al: Lymphocytic infiltration of the skin Jessner-Kanof after treatment with a hydroquinone-containing bleaching cream. Arch Dermatol 142(12):1655-1656, 2006
96. Braddock SW et al: Clinical and immunologic studies in reticular erythematous mucinosis and Jessner's lymphocytic infiltrate of skin. J Am Acad Dermatol 28(5 Pt 1):691-695, 1993
97. Jessner M: Lymphocytic infiltration of the skin. Arch Dermatol Syphilol 68:447, 1953
98. Guillaume JC et al: Crossover study of
thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin.
Arch Dermatol 131(9):1032-1035, 1995
99. Toonstra J et al: Jessner's lymphocytic infiltration of the skin. A clinical study of 100 patients. Arch Dermatol 125(11):1525-1530, 1989
100. Ashworth J, Turbitt M, MacKie R: A comparison of the dermal lymphoid infiltrates in discoid lupus erythematosus and Jessner's lymphocytic infiltrate of the skin using the monoclonal antibody Leu 8. J Cutan Pathol 14(4):198-201, 1987
101. Rijlaarsdam JU et al: Characterization of the dermal infiltrates in Jessner's lymphocytic infiltrate of the skin, polymorphous light eruption and cutaneous lupus erythematosus: Differential diagnostic and pathogenetic aspects. J Cutan Pathol 17(1):2-8, 1990
102. Willemze R, Vermeer BJ, Meijer CJ: Immunohistochemical studies in lymphocytic infiltration of the skin (Jessner) and discoid lupus erythematosus. A comparative study. J Am Acad Dermatol 11(5 Pt 1):832-840, 1984
103. Akasu R, Kahn HJ, From L: Lymphocyte markers on formalin-fixed tissue in Jessner's lymphocytic infiltrate and lupus erythematosus. J Cutan Pathol 19(1):59-65, 1992
104. Poenitz N et al: Jessner's lymphocytic infiltration of the skin: A CD8+ polyclonal reactive skin condition. Dermatology 207(3):276-284, 2003
105. Hafejee A, Winhoven S, Coulson IH: Jessner's lymphocytic infiltrate responding to oral
auranofin.
J Dermatolog Treat 15(5):331-332, 2004